More Articles
Abbott is launching a new clinical trial designed to improve care for patients with both atrial fibrillation (AFib) and heart failure with preserved ejection fraction (HFpEF).
The TAP-CHF trial is…
Researchers have uncovered new clues about why subtle changes in potassium levels can cause a person to experience serious heart rhythm issues. The group also found a way to potentially alleviate such issues, sharing their findings in…
Catheter ablation provides more value as a first-line treatment for paroxysmal atrial fibrillation (AFib) than antiarrhythmic medications, according to a new meta-analysis published in JAMA Cardiology.
…
Annual foot exams provide clinicians with a valuable opportunity to screen diabetic patients for atrial fibrillation (AFib), according to new data presented at EHRA 2021, a virtual scientific congress of the European Society of…
Marijuana users with a cardiac arrhythmia are much more likely to die when hospitalized, according to new data presented at EHRA 2021, a virtual scientific congress of the European Society of Cardiology (ESC).
…
The U.S. Preventive Services Task Force (USPSTF) has determined that there is not enough evidence to make an official recommendation on screening for atrial fibrillation (AFib) among asymptomatic adults 50 years old and older. In 2018…
Rhythm Therapeutics, a Chicago-based healthcare technology company, has received a grant for up to $3.67 million to ramp up work on a new gene therapy treatment for atrial fibrillation (AFib). The technique involves identifying…
The FDA has announced that Medtronic is recalling multiple implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) due to an “unexpected and rapid decrease in battery life.” This is…
SGLT2 inhibitors are associated with a significant reduction in atrial arrhythmias and sudden cardiac death in patients with Type 2 diabetes (T2D), according to new findings published in Heart Rhythm.
…
Updating old protocols helped a team of specialists improve the quality of care they provide for atrial fibrillation (AFib) patients. The group shared its story in a new analysis for JACC: Clinical Electrophysiology.…
Transcatheter mitral valve repair (TMVR) outcomes are worse when patients present with a history of atrial fibrillation (AFib), according to new research published in Circulation: Cardiovascular Interventions. However, TMVR…
American Indians face a higher risk of non-hemorrhagic stroke than people from any other racial or ethnic group, according to a new analysis published in the Journal of the American Heart Association. This was found to…
Atrial fibrillation (AFib) and atrial flutter (AFL) are becoming more and more common in the United States as time goes, according to a new study published in the American Journal of Cardiology. Due to an aging…
The FDA recently warned that lamotrigine, an antiseizure medication primarily sold under the name Lamictal, could be harmful for patients with certain cardiac conditions. The warning left some healthcare providers feeling…
Catheter ablation is a more beneficial treatment option for heart failure patients with atrial fibrillation (AFib) than standard antiarrhythmic drug therapy, according to new findings published in Circulation. …
Drinking certain energy drinks may cause significant damage to the heart, according to new findings published in Food and Chemical Toxicology.
“Because the consumption of…
Researchers have found that using an AI-based analysis tool can make implantable loop recorders (ILRs) more effective at detecting atrial fibrillation (AFib) episodes.
The team’s…
High blood pressure can directly lead to atrial fibrillation (AFib), according to new findings published in the European Journal of Preventive Cardiology. The study’s authors noted that this is yet another reason to…
Sudden cardiac arrest can be much more fatal when a patient is already battling COVID-19, according to a new study published in European Heart Journal. This is true for both out-of-hospital cardiac arrest (OHCA) and in-…
A new feature in the Apple iPhone 12 appears to have an unexpected—and potentially dangerous—side effect: it can deactivate a person’s implantable cardiac device.
Cardiologists at…
Direct oral anticoagulants (DOACs) and warfarin are equally effective as a treatment option for atrial fibrillation (AFib) patients with bioprosthetic heart valves (BHVs), according to a new study published in the American…